We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+11.49%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$601M
AUM Growth
+$89M
Cap. Flow
+$40.9M
Cap. Flow %
6.81%
Top 10 Hldgs %
41.06%
Holding
94
New
4
Increased
28
Reduced
31
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 19.55%
3 Consumer Discretionary 10.9%
4 Industrials 10.05%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IR icon
26
Ingersoll Rand
IR
$33B
$10M 1.67%
153,600
+43,800
+40% +$2.59M
ONON icon
27
On Holding
ONON
$11.6B
$8.27M 1.38%
250,700
+33,500
+15% +$1.02M
DXCM icon
28
DexCom
DXCM
$27.2B
$8.08M 1.35%
62,900
+17,900
+40% +$2.16M
GPK icon
29
Graphic Packaging
GPK
$3.25B
$8M 1.33%
332,900
-43,000
-11% -$1.08M
ALGN icon
30
Align Technology
ALGN
$12B
$7.96M 1.32%
22,500
-17,800
-44% -$5.67M
TMO icon
31
Thermo Fisher Scientific
TMO
$213B
$6.41M 1.07%
12,280
+93
+0.8% +$50.2K
EFA icon
32
iShares MSCI EAFE ETF
EFA
$76.1B
$6.36M 1.06%
87,700
-44,500
-34% -$3.23M
DHR icon
33
Danaher
DHR
$135B
$6.05M 1.01%
28,415
+28
+0.1% +$5.93K
ADBE icon
34
Adobe
ADBE
$84.3B
$5.85M 0.97%
11,958
-50
-0.4% -$20.1K
ABNB icon
35
Airbnb
ABNB
$81.6B
$5.47M 0.91%
42,700
-58,100
-58% -$6.8M
CRM icon
36
Salesforce
CRM
$129B
$5.18M 0.86%
24,529
-550
-2% -$112K
FSLR icon
37
First Solar
FSLR
$22.1B
$5.06M 0.84%
26,600
-22,500
-46% -$4.46M
UNH icon
38
UnitedHealth
UNH
$385B
$4.62M 0.77%
9,605
-50
-0.5% -$24.4K
AVGO icon
39
Broadcom
AVGO
$1.87T
$4.6M 0.77%
53,000
-300
-0.6% -$21.4K
ABBV icon
40
AbbVie
ABBV
$454B
$4.5M 0.75%
33,416
+100
+0.3% +$14.7K
AMZN icon
41
Amazon
AMZN
$2.51T
$4.5M 0.75%
34,535
+110
+0.3% +$12.6K
CCI icon
42
Crown Castle
CCI
$32.5B
$4.14M 0.69%
36,315
-9,200
-20% -$1.1M
CHD icon
43
Church & Dwight Co
CHD
$22.8B
$3.61M 0.6%
36,010
-150
-0.4% -$14.1K
PG icon
44
Procter & Gamble
PG
$342B
$3.2M 0.53%
21,077
-200
-0.9% -$30.1K
AMT icon
45
American Tower
AMT
$76.7B
$2.7M 0.45%
13,934
GIS icon
46
General Mills
GIS
$19B
$2.55M 0.42%
33,248
-130
-0.4% -$11.1K
MASI
47
DELISTED
Masimo
MASI
$2.05M 0.34%
12,452
BCE icon
48
BCE
BCE
$19.8B
$1.97M 0.33%
43,150
-500
-1% -$23.3K
EW icon
49
Edwards Lifesciences
EW
$48.3B
$1.87M 0.31%
19,800
JNJ icon
50
Johnson & Johnson
JNJ
$624B
$1.83M 0.3%
11,052
-134
-1% -$21.6K

Similar funds

De Burlo Group's Q2 2023 Portfolio in Review

As of Q2 2023, De Burlo Group held 94 positions worth $601M, up 17% from $512M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

De Burlo Group deployed $40.9M of net new capital in Q2 2023, opening 4 new positions and adding to 28 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 114,300 shares worth $21.4M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $7.6M trimmed.

  • De Burlo Group's largest Q2 2023 buy was iShares Russell 2000 ETF: 114,300 shares worth $21.4M.
  • De Burlo Group added most to Eli Lilly in Q2 2023, an estimated $18.2M increase.
  • De Burlo Group's biggest Q2 2023 reduction was Tesla, cutting an estimated $7.6M.
  • De Burlo Group fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $16.9M.
  • De Burlo Group's ten largest holdings make up 41% of its $601M portfolio in Q2 2023.
  • De Burlo Group opened 4 new positions and closed 8 in Q2 2023.
  • De Burlo Group's portfolio value rose 17% quarter-over-quarter to $601M.

Based on De Burlo Group's 13F filing for Q2 2023, filed 14 Aug 2023.